AI in Neonatal Care Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Report Overview

The global AI in neonatal care market reached US$ XX million in 2023 and is expected to reach US$ XX million by 2031 growing with a CAGR of XX % during the forecast period 2024-2031.

Artificial intelligence (AI) in the neonatal care market refers to the integration and application of machine learning algorithms and computational technologies to enhance the quality of care provided to newborns, particularly those who are premature or critically ill. This market encompasses various AI-driven solutions and devices designed to improve monitoring, diagnosis, and treatment in neonatal intensive care units (NICUs) and other neonatal care settings.

AI would be an integral part of future healthcare, especially in complex settings such as neonatal intensive care, to support shared clinical decision-making, providing efficient personalized neonatal care while reducing avoidable errors. 

Novel application of AI in neonatal medicine is already improving our understanding of neuroanatomic phenotypes, prediction and disease modeling, seizure analysis, and optimal ventilatory strategies. Current AI approaches in neonatal medicine include tools for disease prediction and risk stratification, neurological diagnostic support, and novel image recognition technologies.

Market Scope

For more details on this report - Request for Sample

Market Dynamics: Drivers

Technological advancements

The demand for the global  AI in neonatal care market is driven by multiple factors. One of the primary factors is that technological advancements help to drive this market growth.

Continuous advancements in technology are vital in driving the AI in neonatal care market. The development of AI-powered diagnostic tools, miniaturized monitoring systems, and non-invasive ventilation options are transforming how care is delivered. Innovations such as wireless monitoring systems and home-based newborn care devices are emerging, allowing for better monitoring and management of neonatal health in various settings.

The AI in the neonatal care industry is increasingly prioritizing family-centered and developmental care for newborns. Neonatal Intensive Care Units (NICUs) are working to minimize neonatal stressors, such as excessive noise and bright lights, to ensure comprehensive holistic care for infants. New features like wireless capabilities and portability are being integrated into neonatal care devices, offering a fresh perspective on traditional neonatal care equipment.

Moreover, key player's strategies such as partnerships & collaborations and technologically advanced products would drive this market growth. For instance, in July 2024, a collaborative research group formed by the UCL Department of Medical Physics and Biomedical Engineering, along with UCL Hospitals, is preparing to introduce NeoSCB. This initiative aims to enhance neonatal care through an AI-driven jaundice screening application designed specifically for midwives.

Also, in August 2023, Cardinal Health unveiled its advanced NTrainer System 2.0, a medical device aimed at assisting premature and newborn infants in developing the oral coordination skills necessary for quicker transitions to independent feeding. 

This innovation is designed to help reduce the length of stay in neonatal intensive care units (NICUs). The system employs real-time assessment technology, equipping clinicians with objective data to monitor an infant's development of pre-feeding skills, while also providing reassurance to parents regarding their child's progress and potential for thriving after leaving the hospital.

Restraints

Factors such as the high cost of implementation,  quality & availability of data, integration with existing systems, ethical & privacy concerns, and regulatory & compliance issues are expected to hamper the market.

Market Segment Analysis

The global  AI in neonatal care market is segmented based on product, application, end-user, and region.

The thermoregulation devices segment accounted for approximately 56.5% of the global  AI in neonatal care market share

The thermoregulation devices segment is expected to hold the largest market share over the forecast period. The segment is driven by advancements in technology and increasing awareness of the importance of maintaining optimal body temperature in newborns, especially those who are premature or have low birth weight.

The adoption of thermoregulation devices is growing owing to innovations in incubators and warmers focusing on family-centric and developmental care. Thermoregulation and heat loss prevention after birth and during neonatal intensive-care unit stabilization of extremely low-birth-weight infants.

Moreover, key players in the industry introducing innovative product launches helps to drive this segment growth in the market. One of the major players in the industry Vygon SAS introduced the Neohelp a sterile polyethylene suit designed to prevent hypothermia in newborns, particularly premature and low birth weight infants. It is intended for use during the critical "Golden Hour" after birth to maintain body temperature and regulate heat loss. 

Neohelp is suitable for babies weighing less than 1 kg up to over 2.5 kg, making it versatile for a range of neonatal sizes. The suit consists of a double layer of polyethylene that creates a greenhouse effect, reducing heat loss through radiation, convection, and evaporation. It also features a hood to limit heat dispersion from the head and pre-formed foam to keep the baby's head in a neutral position and provide a barrier against conductive heat loss.

In addition, major player's key developments and innovative technologies drive this market growth. For instance, in January 2024, Arab Health is set to unveil an innovative replica of labor delivery and neonatal room technologies. This event will highlight the integration of advanced medical technologies within these essential healthcare environments for the first time.

Also, in August 2021, Innocens BV used predictive AI to protect the most vulnerable newborns. It helps efforts in early sepsis detection and treatment as just the first step in a broader journey to leverage AI for enhancing outcomes for newborns. Beyond implementing this solution in additional NICU hospitals and systems, foresee the potential to apply a similar model-driven strategy to identify other complications associated with prematurity, including brain injury, chronic lung disease, and retinopathy, at earlier stages.

Market Geographical Analysis

North America accounted for approximately 43.5% of the global  AI in neonatal care market share

North America region is expected to hold the largest market share over the forecast period owing to the increasing incidence of premature births, enhanced patient safety and monitoring, and rising demand for house care solutions drive this market growth in this region.

According to March of Dimes stats in 2022, there were 380,548 preterm births in the United States, representing 10.4% of live births. From the same sources, 1 in 10 babies (10.4% of live births) was born preterm in the United States.

Moreover, in this region, a major number of key player's presence, government initiatives & support,  product launches & approvals,  technological advances, and well-advanced healthcare infrastructure would propel this market growth. For instance, in September 2023, at the Clinton Global Initiative meeting, D.C. Safe Babies Safe Moms announced a project utilizing artificial intelligence to enhance maternal and infant health outcomes. The initiative aims to develop a safety surveillance system that healthcare providers can use to identify risks and customize care for birthing individuals and their babies.

Also, in May 2023, Sibel Health announced that its ANNE One platform received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for continuous monitoring of neonates and infants up to 2 years old, regardless of gestational age. The ANNE One platform is now approved as a clinical-grade continuous monitoring solution suitable for neonates, infants, and adults.

Market Segmentation

By Product 

• Thermoregulation Devices 
  • Radiant Warmers
  •  Neonatal Incubators 
  • Neonatal Cooling Systems
•  Monitoring Systems 
  • Vital Signs Monitors
  •  Brain Monitoring Systems 
  • Blood Gas Monitoring Systems 
• Phototherapy Equipment
  •  LED and CFL Phototherapy Units 
  • Phototherapy Eye Masks 
• Ventilation Systems 
• Screening Devices 
• Others

By Application

• Neonatal Hypothermia & Low Birth Weight
• Jaundice 
• Gastrointestinal Diseases
• Respiratory Diseases
• Retinopathy 
• Sepsis
• Others

By End-User

•  Hospitals
•  Pediatric and Neonatal Clinics
•  Nursing Homes 
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • The rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global AI players in neonatal care include IBM, Sibel Health, Inc., CuboAi, Invidyo, CergenX, Snorble, and LittleOne.Care, Bloom Standard, Wadhwani AI, and Maxi-Cosi among others.

Key Developments

• In April 2024, Sibel Health announced that it had been awarded a $17.5 million grant from the Bill & Melinda Gates Foundation to enhance the use of its FDA-cleared wireless monitoring solution, ANNE One. This initiative aims to support labor triage and continuous maternal health monitoring in low- and middle-income countries (LMICs) to help reduce obstetrical morbidity and mortality.
• In January 2024, Maxi-Cosi, a prominent baby gear brand owned by Dorel Industries Inc., unveiled its innovative See Pro 360° Baby Monitor. This cutting-edge device aims to revolutionize the way parents interact with their babies by incorporating groundbreaking CryAssist technology. Powered by artificial intelligence (AI), the CryAssist feature can accurately translate a baby's cries, helping parents determine if their little one is sleepy, fussy, gassy, agitated, or hungry.

Why Purchase the Report?

• To visualize the global AI in neonatal care market segmentation is based on product, application, end-user, and region and it understands key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development. 
• Excel data sheet with numerous data points of the AI in neonatal care market with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in Excel consisting of key products of all the major players.

The global AI in neonatal care market report would provide approximately 62 tables, 68 figures, and 184 pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies